Venkateswarlu Kanamarlapudi is a Professor of Molecular Cell Biology and Pharmacology at Swansea University Medical School.
Prof. Kanamarlapudi main research interests lie in understanding GPCR-, inositol lipids- and small GTPases-mediated cell signalling in health and disease. His group recent efforts have also been focussed on the development of targeted therapy for pancreatic cancer and the improvement of LVADs.
Prof. Kanamarlapudi obtained BSc (Biology & Chemistry) from Acharya Nagarjuna University, MSc (Biochemistry) from the University of Hyderabad, MTech (Biotechnology) from IIT-Kharagpur and PhD from the University of Sheffield (researched on antifungal drugs mode of action and fungal resistance under Prof. Steve Kelly’s supervision).
Before Joining Swansea, Prof. Kanamarlapudi worked as a research scientist at AstraZeneca (India) on anti-microbial drugs, post-doctoral researcher in the School of Biochemistry at the University of Bristol on the regulation of ARF cell signalling by inositol lipids, and BBSRC David Phillips Research Fellow and Lecturer in School of Physiology and Pharmacology at the University of Bristol on ARF and inositol lipid signalling in health and disease.
Based on his research accomplishments, Prof. Kanamarlapudi has been elected as a fellow of several learned societies (FRSB, FRSC, FLSW, FABAP, FAPAS, FNABS) and received DSc (Doctor of Science) from Swansea University.